China Pharmaceutical University - Jiangsu Haizhi Biopharmaceutical Co., Ltd. "Joint Aesthetics Laboratory" Signing and Unveiling Ceremony

China Pharmaceutical University - Jiangsu Haizhi Biopharmaceutical Co., Ltd. "Joint Aesthetic Laboratory" Signing and Unveiling Ceremony

 

On September 14, the signing and unveiling ceremony of the "Joint Aesthetic Laboratory" between China Pharmaceutical University and Jiangsu Haizhi Biopharmaceutical Co., Ltd. was held in the conference room on the 5th floor of Building A6, Intelligent Manufacturing Industrial Park, Jiangbei New District, Nanjing.

 

Wang Kelong, Deputy Secretary of the Party Working Committee of the Jiangbei New District Intelligent Manufacturing Industry Development Management Office, Minister of the Industry Development Department Chen Hongbin, Executive Vice President of the Alumni Association of China Pharmaceutical University and former Vice President Lu Tao, Secretary of the Party Committee of the School of Science Zhou Xinhui, Dean Tang Weifang, Professor Wang Yue, General Manager of Jiangsu Haizhi Biopharmaceutical Co., Ltd. Xu Liyou, Deputy General Manager Yang Zheng, and representatives of senior management attended the signing ceremony.

 

Before the meeting, the attendees visited the investment promotion exhibition center of the Nanjing Intelligent Manufacturing Industrial Park accompanied by Secretary Wang Kelong.

 

 

At the signing and unveiling ceremony, Secretary Wang Kelong detailed the development of the park and expressed that the joint laboratory would serve as an opportunity to expand communication and cooperation between the park and universities, deepen integrated development in education, technology, and talent, and look forward to a long-term partnership with China Pharmaceutical University to further promote the development of the biopharmaceutical industry in the intelligent industrial park.

 

 

Lu Tao, Executive Vice President of the Alumni Association of China Pharmaceutical University, congratulated the establishment of the Joint Aesthetic Laboratory and praised the two founders of Haizhi Biopharmaceutical as outstanding alumni of China Pharmaceutical University for their remarkable achievements in the medical beauty and aesthetic fields. He also wished both parties high-quality research and development results during the joint laboratory construction process.

 

Secretary Zhou Xinhui introduced the details of the School of Science. He stated that the school has achieved abundant research results in recent years, and the leadership of the school attaches great importance to deep cooperation with enterprises. This joint aesthetic laboratory is the first project of the School of Science involving the medical beauty and health field, and he hopes that the cooperation will become a model for industry-university-research collaboration, achieving a win-win situation for both the school and the enterprise.

 

Yang Zheng, Deputy General Manager of Haizhi Biopharmaceutical and an alumnus of the 1993 class, introduced the specific situation of Jiangsu Haizhi Biopharmaceutical Co., Ltd. Xu Liyou, General Manager of Haizhi Biopharmaceutical and also an alumnus of the 1993 class, fully affirmed the research results of the School of Science and looked forward to further strengthening deep cooperation with the School of Science to promote the Joint Aesthetic Laboratory to develop into an innovative cooperation and win-win research and development transformation platform.

 

Professor Wang Yue, the project leader of the joint laboratory, stated that the team would leverage its advantages to actively cooperate with Haizhi Biopharmaceutical's product layout and core technology upgrade needs, promote technological innovation and industrial integration, jointly advance the development of high-end raw materials for medical beauty, and innovate key formulation technologies for end products, and look forward to Haizhi Biopharmaceutical becoming a leader in the medical beauty industry.

 

 

Subsequently, both parties jointly signed a strategic cooperation agreement and unveiled the "Joint Aesthetic Laboratory." The attendees expressed that both parties would take this as an opportunity to seize the development opportunities in the medical beauty industry, continuously seek innovation, and contribute to the construction of a healthy China.

 

Jiangsu Haizhi Biopharmaceutical Co., Ltd.

 

 

Jiangsu Haizhi Biopharmaceutical Co., Ltd. (abbreviated as: Haizhi Biopharmaceutical) is located in Jiangbei New District, Nanjing. It is a comprehensive high-tech enterprise integrating research and development, production, and sales, focusing on the research and development and industrialization of local transdermal drug delivery formulations. Haizhi Biopharmaceutical has successively obtained a series of independently developed scientific research results, applied for 32 patents, and registered 76 trademarks. Since 2018, it has been recognized as a private technology enterprise in Jiangsu Province, a national/Jiangsu Province/Nanjing City high-tech enterprise, a technology-based small and medium-sized enterprise, and a "specialized, refined, distinctive, and innovative" small and medium-sized enterprise in Nanjing.

 

Haizhi Biopharmaceutical has a strong R&D team, professional technology, 100,000-level and 10,000-level clean rooms, and fully qualified and experienced in providing value-added services in product research and development, registration, production, and market launch, including R&D registration production CDMO/private label production ODM/contract manufacturing CMO services. It has established multiple production lines in medical beauty, functional skincare, nursing, and oral care.

 

From 2020 to the present, Haizhi's average annual revenue growth rate has exceeded 70%, achieving multiple scientific and technological achievement transformation projects (6 registered ordinary cosmetic products, 9 entrusted production products of ordinary cosmetics, 19 Class II medical device licensed products, and 9 Class II medical device registrant licensed and entrusted production products), driving nearly a hundred people to start businesses and find employment, and is one of the key supported biopharmaceutical enterprises in the Jiangbei New District Intelligent Manufacturing Park.

 

While focusing on independent research and development, the company has established deep cooperation with several laboratories, including China Pharmaceutical University and Nanjing University, relying on its strong R&D background, focusing on biological tissue engineering materials, and is committed to the repair of skin and mucosal injuries, winning multiple national invention patents.

 

Haizhi has been invited multiple times by the National Bureau of Medical Device Evaluation Center, various provincial bureau evaluation and inspection centers, adverse reaction monitoring centers, and other departments to actively participate in the formulation of relevant industry standards, product registration review guidelines, research topic discussions, and on-site research activities. It has published multiple analytical methodology research reports and human efficacy evaluation verification reports in core scientific and Chinese core journals in collaboration with the Shandong Provincial Food and Drug Evaluation Center, Jiangsu Provincial Drug Research Institute, and Nanjing Medical University School of Public Health, contributing positively to the standardized development of the industry.